A Study To Assess The Safety Of PF-06342674 In Adults With Type 1 Diabetes
Status:
Completed
Trial end date:
2016-09-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and
immunogenicity of multiple doses of PF-06342674. Several dose levels will be evaluated.